253 related articles for article (PubMed ID: 16949388)
1. CYP1A1 and CYP1B1 polymorphisms and their association with estradiol and estrogen metabolites in women who are premenopausal and perimenopausal.
Sowers MR; Wilson AL; Kardia SR; Chu J; McConnell DS
Am J Med; 2006 Sep; 119(9 Suppl 1):S44-51. PubMed ID: 16949388
[TBL] [Abstract][Full Text] [Related]
2. Sex steroid metabolism polymorphisms and mammographic density in pre- and early perimenopausal women.
Crandall CJ; Sehl ME; Crawford SL; Gold EB; Habel LA; Butler LM; Sowers MR; Greendale GA; Sinsheimer JS
Breast Cancer Res; 2009; 11(4):R51. PubMed ID: 19630952
[TBL] [Abstract][Full Text] [Related]
3. Association of genetic polymorphisms with serum estrogens measured multiple times during a 2-year period in premenopausal women.
Lurie G; Maskarinec G; Kaaks R; Stanczyk FZ; Le Marchand L
Cancer Epidemiol Biomarkers Prev; 2005 Jun; 14(6):1521-7. PubMed ID: 15941966
[TBL] [Abstract][Full Text] [Related]
4. Cognitive functioning and sex steroid hormone gene polymorphisms in women at midlife.
Kravitz HM; Meyer PM; Seeman TE; Greendale GA; Sowers MR
Am J Med; 2006 Sep; 119(9 Suppl 1):S94-S102. PubMed ID: 16949394
[TBL] [Abstract][Full Text] [Related]
5. Sex steroid hormone gene polymorphisms and depressive symptoms in women at midlife.
Kravitz HM; Janssen I; Lotrich FE; Kado DM; Bromberger JT
Am J Med; 2006 Sep; 119(9 Suppl 1):S87-93. PubMed ID: 16949393
[TBL] [Abstract][Full Text] [Related]
6. Vasomotor symptom prevalence is associated with polymorphisms in sex steroid-metabolizing enzymes and receptors.
Crandall CJ; Crawford SL; Gold EB
Am J Med; 2006 Sep; 119(9 Suppl 1):S52-60. PubMed ID: 16949389
[TBL] [Abstract][Full Text] [Related]
7. Genetic polymorphisms in estrogen-metabolizing genes and breast cancer survival.
Long JR; Cai Q; Shu XO; Cai H; Gao YT; Zheng W
Pharmacogenet Genomics; 2007 May; 17(5):331-8. PubMed ID: 17429315
[TBL] [Abstract][Full Text] [Related]
8. Variants in estrogen metabolism and biosynthesis genes and urinary estrogen metabolites in women with a family history of breast cancer.
Greenlee H; Chen Y; Kabat GC; Wang Q; Kibriya MG; Gurvich I; Sepkovic DW; Bradlow HL; Senie RT; Santella RM; Ahsan H
Breast Cancer Res Treat; 2007 Mar; 102(1):111-7. PubMed ID: 16850246
[TBL] [Abstract][Full Text] [Related]
9. Endogenous estradiol and its association with estrogen receptor gene polymorphisms.
Sowers MR; Jannausch ML; McConnell DS; Kardia SR; Randolph JF
Am J Med; 2006 Sep; 119(9 Suppl 1):S16-22. PubMed ID: 16949384
[TBL] [Abstract][Full Text] [Related]
10. A common CYP1B1 polymorphism is associated with 2-OHE1/16-OHE1 urinary estrone ratio.
Paracchini V; Pedotti P; Raimondi S; Garte S; Bradlow HL; Sepkovic DW; Taioli E
Clin Chem Lab Med; 2005; 43(7):702-6. PubMed ID: 16207128
[TBL] [Abstract][Full Text] [Related]
11. The Val432Leu polymorphism of the CYP1B1 gene is associated with differences in estrogen metabolism and bone density.
Napoli N; Rini GB; Serber D; Giri T; Yarramaneni J; Bucchieri S; Camarda L; Di Fede G; Camarda MR; Jain S; Mumm S; Armamento-Villareal R
Bone; 2009 Mar; 44(3):442-8. PubMed ID: 18977467
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of SNP in estrogen-metabolizing enzymes for ovarian, endometrial, and breast cancers in Novosibirsk, Russia.
Gulyaeva LF; Mikhailova ON; PustyInyak VO; Kim IV; Gerasimov AV; Krasilnikov SE; Filipenko ML; Pechkovsky EV
Adv Exp Med Biol; 2008; 617():359-66. PubMed ID: 18497059
[TBL] [Abstract][Full Text] [Related]
13. Aromatase gene (CYP 19) polymorphisms and endogenous androgen concentrations in a multiracial/multiethnic, multisite study of women at midlife.
Sowers MR; Wilson AL; Kardia SR; Chu J; Ferrell R
Am J Med; 2006 Sep; 119(9 Suppl 1):S23-30. PubMed ID: 16949385
[TBL] [Abstract][Full Text] [Related]
14. Relationship between single nucleotide polymorphisms in CYP1A1 and CYP1B1 genes and the bone mineral density and serum lipid profiles in postmenopausal Japanese women taking hormone therapy.
Quan J; Yahata T; Tamura N; Nagata H; Tanaka K
Menopause; 2009; 16(1):171-6. PubMed ID: 18779756
[TBL] [Abstract][Full Text] [Related]
15. Urinary 2-hydroxyestrone/16alpha-hydroxyestrone ratio and family history of breast cancer in premenopausal women.
Ursin G; London S; Yang D; Tseng CC; Pike MC; Bernstein L; Stanczyk FZ; Gentzschein E
Breast Cancer Res Treat; 2002 Mar; 72(2):139-43. PubMed ID: 12038704
[TBL] [Abstract][Full Text] [Related]
16. African American-preponderant single nucleotide polymorphisms (SNPs) and risk of breast cancer.
Kato I; Cichon M; Yee CL; Land S; Korczak JF
Cancer Epidemiol; 2009 Jul; 33(1):24-30. PubMed ID: 19679043
[TBL] [Abstract][Full Text] [Related]
17. The association of bone mineral density with estrogen receptor gene polymorphisms.
Greendale GA; Chu J; Ferrell R; Randolph JF; Johnston JM; Sowers MR
Am J Med; 2006 Sep; 119(9 Suppl 1):S79-86. PubMed ID: 16949392
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms in genes involved in the estrogen pathway and mammographic density.
Dumas I; Diorio C
BMC Cancer; 2010 Nov; 10():636. PubMed ID: 21092186
[TBL] [Abstract][Full Text] [Related]
19. Role of estradiol metabolism and CYP1A1 polymorphisms in breast cancer risk.
Taioli E; Bradlow HL; Garbers SV; Sepkovic DW; Osborne MP; Trachman J; Ganguly S; Garte SJ
Cancer Detect Prev; 1999; 23(3):232-7. PubMed ID: 10337002
[TBL] [Abstract][Full Text] [Related]
20. Ethnic-related differences in the frequency distribution of genetic polymorphisms in the CYP1A1 and CYP1B1 genes in Japanese and Caucasian populations.
Inoue K; Asao T; Shimada T
Xenobiotica; 2000 Mar; 30(3):285-95. PubMed ID: 10752643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
